The Mattis Dementia Rating Scale (DRS) was used to distinguish between 50 dementia of the Alzheimer's type (DAT) and 50 Parkinson's disease (PD) subjects matched for age, education, and DRS total score. Despite a similar level of overall cognitive impairment, the DAT group earned significantly lower scores than did the PD group on the Memory subscale, while the PD group displayed lower scores than did the DAT subjects on the Construction subscale. A jackknifed, stepwise, linear discriminant function using the five DRS subscales revealed that the Memory, Construction, and Initiation subtests significantly distinguished the groups. These results suggest qualitative differences in the dementias of DAT and PD patients and reveal that such differences can emerge on brief mental status examinations.
Get full access to this article
View all access options for this article.
References
1.
1. Hyman BT, van Hoesen GW, Damasio AR, Barnes CL. Alzheimer's disease: cell specific pathology isolates the hippocampal formation. Science1984; 225:1168–1170.
2.
2. Terry RD, Katzman R.Senile dementia of the Alzheimer's type. Ann Neurol1983; 14:497–506.
3.
3. Terry RD, Peck A, De Teresa R, et al. Some morphometric aspects of the brain in SDAT. Ann Neurol1981; 10:184–192.
4.
4. Huff FJ, Becker JT, Belle SH, et al. Cognitive deficits and clinical diagnosis of Alzheimer's disease. Neurology1987; 37:1119–1124.
5.
5. Joynt RJ, Shoulson I.Dementia. In: Heilman KM, Valenstein E, Eds. Clinical neuropsychology. New York: Oxford University Press, 1985: 453–479.
6.
6. Moss MB, Albert MS. Alzheimer's disease and other dementing disorders. In: Albert MS, Moss MB, Eds. Geriatric neuropsychology. New York: Guilford, 1988: 145–178.
7.
7. Cummings JL. The dementia of Parkinson's disease: prevalence, characteristics, neurobiology, and comparison with the dementia of the Alzheimer type. Eur Neurol1988; 28 (Suppl):15–23.
8.
8. Cummings JL, Benson DF. Subcortical dementia: review of an emerging concept. Arch Neurol1984; 41:874–879.
9.
9. Huber SJ, Shuttleworth EC. Neuropsycological assessment of subcortical dementia. In: Cummings JL, ed. Subcortical dementia. New York: Oxford University Press, 1990: 71–86.
10.
10. Mayeux R, Stern Y, Rosen J, Benson DF. Is “subcortical dementia” a recognizable clinical entity?Ann Neurol1983; 14:278–283.
11.
11. Pillon B, Dubois B, Ploska A, Agid Y.Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy. Neurology1991; 41:634–643.
12.
12. Huber SJ, Shuttleworth EC, Paulson GW, et al. Cortical vs. subcortical dementia: neuropsychological differences. Arch Neurol1986; 43:392–394.
13.
13. Cummings JL, Darkins A, Mendez M, et al. Alzheimer's disease and Parkinson's disease: comparison of speech and language alterations. Neurology1988; 38:680–684.
14.
14. Randolph C, Braun AR, Goldberg TE, Chase TN. Semantic fluency in Alzheimer's, Parkinson's and Huntington's disease: dissociation of storage and retrieval failures. Neuropsychol1993; 7:82–88.
15.
15. Pillon B, Dubois B, Lhermitte F, Agid Y.Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease and Alzheimer's disease. Neurology1986; 36:1179–1185.
17. Salmon DP, Kwo-on-Yuen PF, Heindel WC, et al. Differentiation of Alzheimer's disease and Huntington's disease with the Dementia Rating Scale. Arch Neurol1989; 46:1204–1208.
18.
18. Cumings JL. Subcortical dementia. New York: Oxford University Press, 1990.
19.
19. Shay KA, Duke LW, Conboy T, et al. The clinical validity of the Mattis Dementia Rating Scale in staging Alzheimer's dementia. J Geriatr Psychiatry Neurol1991; 4:18–25.
20.
20. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology1984; 34:939–944.
21.
21. Fahn S, Elton RL, et al. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB, Eds. Recent developments in Parkinson's disease. New York: Macmillan, 1987: 153–163.
22.
22. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology1967; 17:427–442.
23.
23. Dooneief G, Mirabello E, Bel K, et al. An estimate of the incidence of depression in idiopathic Parkinson's disease. Arch Neurol1992; 49:305–307.
24.
24. Gotham AM, Brown RG, Marsden CD. Depression in Parkinson's disease: a quantitative and qualitative analysis. J Neurol Neurosurg Psychiatry1986; 49:381–389.
25.
25. Norusis MJ. SPSS for Windows: release 6.0. Chicago: SPSS, 1993.
26.
26. Dixon WJ. BMDP statistical software manual. Berkeley: University of California Press, 1992.
27.
27. Cohen J.A coefficient of agreement for nominal scales. Educ Psychol Meas1960; 20:37–46.
28.
28. Fleiss JL. Statistical methods for rates and proportions, 2nd Ed.New York: Wiley, 1981.
29.
29. Boller F, Mizutani T, Roessmann U, Gambetti P.Parkinson disease, dementia, and Alzheimer disease: clinicopathological correlations. Ann Neurol1980; 7:329–335.
30.
30. Hansen L, Salmon D, Galasko D, et al. The Lewy body variant of Alzheimer's disease: a clinical and pathological entity. Neurology1990; 40:1–8.
